Literature DB >> 9768921

Left ventricular functional improvement after transmyocardial laser revascularization.

K A Horvath1, R Greene, N Belkind, B Kane, D D McPherson, D A Fullerton.   

Abstract

BACKGROUND: Transmyocardial laser revascularization has been used to treat patients with end-stage coronary artery disease that is not amenable to standard revascularization. Although there is evidence of angina relief and quality of life enhancement, there is little information concerning improvement in myocardial contractility. The purpose of this study was to determine whether transmyocardial laser revascularization improves myocardial function in chronically ischemic myocardium.
METHODS: In a model of chronic ischemia by Ameroid occlusion of the circumflex artery, domestic pigs (n = 8) were treated with transmyocardial laser revascularization. Before laser treatment, segmental contraction was assessed at rest and with dobutamine stress echocardiography. Myocardium subtended by the occlusion was compared with that remote from the occlusion. Six weeks after transmyocardial laser revascularization, the animals were restudied at rest and with stress, and then sacrificed. Sham-treated control animals (n = 4) underwent the same procedures but were not treated with transmyocardial laser revascularization. Control animals did not demonstrate significant recovery of function.
RESULTS: Transmyocardial laser revascularization improved resting function in chronically ischemic myocardium by 100%.
CONCLUSIONS: Transmyocardial laser revascularization significantly improves the function of chronically ischemic myocardium. These data may help explain the mechanisms by which transmyocardial laser revascularization is clinically effective.

Entities:  

Mesh:

Year:  1998        PMID: 9768921     DOI: 10.1016/s0003-4975(98)00735-8

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Percutaneous Myocardial Revascularization.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-06

Review 2.  Epicardial gene therapy and laser revascularization.

Authors:  J F Symes
Journal:  Curr Cardiol Rep       Date:  1999-11       Impact factor: 2.931

Review 3.  Transmyocardial laser revascularization.

Authors:  Keith A Horvath
Journal:  J Card Surg       Date:  2008 May-Jun       Impact factor: 1.620

Review 4.  Transmyocardial revascularization devices: technology update.

Authors:  Bogdan A Kindzelski; Yifu Zhou; Keith A Horvath
Journal:  Med Devices (Auckl)       Date:  2014-12-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.